CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹13,454 Cr | ₹12,689 Cr | ₹11,732 Cr | ₹11,925 Cr | ₹11,628 Cr |
What is the latest Total Non-Current Assets ratio of CIPLA ?
Year | Total Non-Current Assets |
---|---|
Mar2025 | ₹13,454 Cr |
Mar2024 | ₹12,689 Cr |
Mar2023 | ₹11,732 Cr |
Mar2022 | ₹11,925 Cr |
Mar2021 | ₹11,628 Cr |
How is Total Non-Current Assets of CIPLA Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹13,454 Cr | 6.03 | |
Mar2024 | ₹12,689 Cr | 8.16 | |
Mar2023 | ₹11,732 Cr | -1.62 | |
Mar2022 | ₹11,925 Cr | 2.55 | |
Mar2021 | ₹11,628 Cr | - |
Compare Total Non-Current Assets of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹120,127.9 Cr | -4.3% | -0.1% | -1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,478.0 Cr | -6.5% | -4.7% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,845.0 Cr | -7.1% | -11.5% | 32.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,327.0 Cr | -5.8% | 6.1% | 13.3% | Stock Analytics | |
MANKIND PHARMA | ₹105,380.0 Cr | -0.6% | 5.1% | 31.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,907.8 Cr | -5.8% | -6.8% | -11% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -4.3% |
-0.1% |
-1% |
SENSEX | -1.2% |
-3.5% |
-0.5% |
You may also like the below Video Courses